Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antiviral drug |
| gptkbp:approvedBy |
gptkb:non-small_cell_lung_cancer
gptkb:cancer pancreatic cancer bladder cancer |
| gptkbp:ATCCode |
L01BC05
|
| gptkbp:CASNumber |
95058-81-4
|
| gptkbp:category |
antineoplastic agent
|
| gptkbp:discoveredBy |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:has_trade_name |
gptkb:Gemzar
|
| gptkbp:hasMolecularFormula |
C9H11F2N3O4
|
| https://www.w3.org/2000/01/rdf-schema#label |
2',2'-difluorodeoxycytidine
|
| gptkbp:IUPACName |
4-amino-1-[(2R,4S,5R)-4-hydroxy-2,5-bis(1,1-difluoroethyl)oxolan-3-yl]pyrimidin-2(1H)-one
|
| gptkbp:mechanismOfAction |
inhibits DNA synthesis
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1637
gptkb:DB00441 60750 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
nausea vomiting rash elevated liver enzymes myelosuppression |
| gptkbp:synonym |
gemcitabine
|
| gptkbp:UNII |
G1LN9045DK
|
| gptkbp:usedFor |
antineoplastic agent
|
| gptkbp:bfsParent |
gptkb:Gemcitabine
|
| gptkbp:bfsLayer |
7
|